BREAST-CANCER MARKER CA-549 AND ITS COMPARISON WITH CA-15.3

被引：0
|
作者：
BHARGAVA, A [1 ]
FERNG, S [1 ]
PALMER, M [1 ]
PETRELLI, N [1 ]
FITZPATRICK, J [1 ]
机构：
[1] ROSWELL PK CANC INST,BUFFALO,NY 14263
来源：
CLINICAL CHEMISTRY | 1990年 / 36卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1052 / 1052
页数：1
相关论文
共 50 条
  • [31] SERUM TISSUE POLYPEPTIDE SPECIFIC ANTIGEN (TPS) IN BREAST-CANCER PATIENTS - COMPARISON WITH CA-15.3 AND CEA
    WILLSHER, PC
    BEAVER, J
    BLAMEY, RW
    ROBERTSON, JFR
    ANTICANCER RESEARCH, 1995, 15 (04) : 1609 - 1611
  • [32] A LONGITUDINAL-STUDY OF CA-549, CEA, AND CA-125 AS BREAST-CANCER MONITORS
    BHARGAVA, AK
    FERNG, S
    MCWILLIAMS, O
    BRAY, KR
    GAUR, PK
    BROWN, W
    NEMOTO, T
    FITZPATRICK, JE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 183 - 183
  • [33] COMPARISON OF CA-15.3 AND CEA IN UNTREATED BREAST-CARCINOMA
    MARTIN, M
    BLOCKX, P
    BECQUART, D
    VRANCKEN, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 315 - 315
  • [34] COMPARISON OF CA-15.3 AND CEA IN UNTREATED BREAST-CARCINOMA
    MARTIN, M
    BLOCKX, P
    BECQUART, D
    VRANCKEN, A
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1988, 26 (05): : 312 - 313
  • [35] SERUM LEVELS AND BIOCHEMICAL CHARACTERISTICS OF CANCER-ASSOCIATED ANTIGEN CA-549, A CIRCULATING BREAST-CANCER MARKER
    BRAY, KR
    KODA, JE
    GAUR, PK
    CANCER RESEARCH, 1987, 47 (22) : 5853 - 5860
  • [36] CA-15.3 DETERMINATION IN PATIENTS WITH BREAST-CANCER - CLINICAL UTILITY FOR THE DETECTION OF DISTANT METASTASES
    BOMBARDIERI, E
    PIZZICHETTA, M
    VERONESI, P
    SEREGNI, E
    BOGNI, A
    MAFFIOLI, L
    JOTTI, GS
    BASSETTO, MA
    ZURRIDA, S
    COSTA, A
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) : 144 - 146
  • [37] INCIDENCE OF ELEVATED SERUM LEVELS OF CA-549 AND CEA IN BREAST-CANCER PATIENTS
    BRAY, KR
    SUCHOCKI, KM
    GAUR, PK
    CLINICAL CHEMISTRY, 1988, 34 (06) : 1296 - 1296
  • [38] CORRELATION OF SERUM LEVELS OF CA-549 TO DISEASE PROGRESSION AND REMISSION IN BREAST-CANCER PATIENTS
    BRAY, KR
    SUCHOCKI, KM
    GAUR, PK
    FASEB JOURNAL, 1988, 2 (05): : A1469 - A1469
  • [39] USE OF SERIAL CARCINOEMBRYONIC ANTIGEN AND CA-15.3 ASSAYS IN DETECTING RELAPSES IN BREAST-CANCER PATIENTS
    MOLINA, R
    ZANON, G
    FILELLA, X
    MORENO, F
    JO, J
    DANIELS, M
    LATRE, ML
    GIMENEZ, N
    PAHISA, J
    VELASCO, M
    BALLESTA, AM
    BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (01) : 41 - 48
  • [40] CA-15.3, CEA AND TPA TUMOR-MARKERS IN THE EARLY DIAGNOSIS OF BREAST-CANCER RELAPSE
    VIZCARRA, E
    LLUCH, A
    CIBRIAN, R
    JARQUE, F
    GARCIACONDE, J
    ONCOLOGY, 1994, 51 (06) : 491 - 496
12345